Trials / Enrolling By Invitation
Enrolling By InvitationNCT06601803
Surgiphor Us in TSA
Effect of Surgiphor (sterile Povidone-Iodine) Wound Irrigation on Rate of Positive Deep Culture and NGS in Primary Total Shoulder Arthroplasty- a Prospective, Randomized Pilot Study
- Status
- Enrolling By Invitation
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 126 (estimated)
- Sponsor
- Rothman Institute Orthopaedics · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Bacteria is occasionally present in the shoulder during shoulder arthroplasty surgery and is hypothesized to increase the risk of failure of the prosthesis. Surgiphor (sterile Povidone-Iodine) wound irrigation, is a solution used in orthopaedic surgery and other surgical fields to kill bacteria intraoperatively. The Iodine dissociates from complex and has antimicrobial properties, causing cell death of bacteria, fungi, and viruses through interactions with proteins, nucleotides, and fatty acids in the cytoplasm and cytoplasmic membrane. This study examines the use of Povidone-Iodine during primary shoulder arthroplasty.
Detailed description
The purpose of this study is to determine the rate of reduction of positive cultures collected before and after wound irrigation with either Surgiphor or sterile normal saline during primary total shoulder arthroplasty
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | sterile saline solution | The shoulder will be washed with normal sterile saline before and after placing the shoulder implant |
| DRUG | Surgiphor | The shoulder will be washed with Surgiphor (Povidone Iodine) before and after placing the shoulder implant |
| PROCEDURE | Sample Collection | During the surgical procedure, 4 swabs of the surgical wound will be taken at various times throughout the procedure |
Timeline
- Start date
- 2024-09-16
- Primary completion
- 2025-09-30
- Completion
- 2025-09-30
- First posted
- 2024-09-19
- Last updated
- 2024-09-19
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06601803. Inclusion in this directory is not an endorsement.